Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2002

Study Completion Date

August 31, 2003

Conditions
Rheumatoid Arthritis
Interventions
DRUG

efalizumab

Trial Locations (52)

10003

Hospital for Joint Disease, ACRC, New York

10029

Mount Sinai School of Medicine, New York

10461

Albert Einstein College of Medicine, The Bronx

11040

Long Island Jewish Medical Center, New Hyde Park

11803

Prem C. Chatpar, M.D., Plainview

13210

State University of New York Upstate Medical University, Syracuse

13326

Bassett Healthcare Clinical Pharmacology Research Center, Cooperstown

15218

nTouch Research Corporation, Pittsburgh

16635

Altoona Center for Clinical Research, Duncansville

19090

Rheumatic Disease Associates, Willow Grove

30033

nTouch Research Corporation, Decatur

30066

nTouch Research Corporation, Marietta

32806

Rheumatology Associates of Central Florida, Orlando

32962

nTouch Research Corporation, Vero Beach

33334

The Center for Rheumatology, Immunology and Arthritis, Fort Lauderdale

33409

Palm Beach Research Center, West Palm Beach

33614

Tampa Medical Group, Tampa

33710

nTouch Research Corporation, St. Petersburg

33765

Clinical Research of West Florida, Clearwater

34102

Anchor Research Center, Naples

35294

University of Alabama at Birmingham, Birmingham

35801

Rheumatology Associates of North Alabama, Huntsville

37920

Volunteer Research Group, LLC, Knoxville

38119

Summit Research Solutions, Inc., Memphis

47714

Tri-State Arthritis and Rheumatology Center, LLC, Evansville

50309

Central Iowa Hospital Corporation, Des Moines

53792

University of Wisconsin, Madison, Madison

63110

Washington University Center for Clinical Studies, St Louis

64114

The Center for Pharmaceutical Research, Kansas City

72205

Little Rock Diagnostic Clinic, Little Rock

72401

NEA Clinic, Jonesboro

73103

McBride Clinic, Inc., Oklahoma City

78705

Austin Rheumatology Research, Austin

79106

Amarillo Center for Clinical Research, Ltd., Amarillo

84403

Physicians' Research Options, LLC, Ogden

85253

Arizona Arthritis Research, PLC, Paradise Valley

85715

Advanced Clinical Therapeutics, LLC, Tucson

89128

Clinical Research Center of Nevada, Las Vegas

90024

UCLA, Los Angeles

90048

Wallace Rheumatic Study Center, Los Angeles

91730

Boling Clinical Trials, Rancho Cucamonga

92120

The San Diego Arthritis and Osteoporosis Medical Clinic, San Diego

92270

Desert Medical Advances, Rancho Mirage

93454

Pacific Arthritis Center, Santa Maria

98502

South Puget Sound Clinical Research, Olympia

92093-0943

University of California at San Diego, La Jolla

06518

Northeast Clinical Research, LLC, Hamden

06611

Clinical Research Consultants, Inc., Trumbull

02215

Beth Israel Deaconess Medical Center, Boston

02720

Phase III Clinical Research, Fall River

Unknown

State University of New York Health Science Center at Brooklyn, Brooklyn

37232-2681

Vanderbilt University, Nashville

All Listed Sponsors
lead

XOMA (US) LLC

INDUSTRY

NCT00034203 - Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis. | Biotech Hunter | Biotech Hunter